Literature DB >> 10713045

Brain copper content and cuproenzyme activity do not vary with prion protein expression level.

D J Waggoner1, B Drisaldi, T B Bartnikas, R L Casareno, J R Prohaska, J D Gitlin, D A Harris.   

Abstract

Prion diseases are neurodegenerative disorders that result from conformational transformation of a normal cell surface glycoprotein, PrP(C), into a pathogenic isoform, PrP(Sc). Although the normal physiological function of PrP(C) has remained enigmatic, the recent observation that the protein binds copper ions with micromolar affinity suggests a possible role in brain copper metabolism. In this study, we have used mice that express 0, 1, and 10 times the normal level of PrP to assess the effect of PrP expression level on the amount of brain copper and on the properties of two brain cuproenzymes. Using mass spectrometry, we find that the amount of ionic copper in subcellular fractions from brain is similar in all three lines of mice. In addition, the enzymatic activities of Cu-Zn superoxide dismutase and cytochrome c oxidase in brain extracts are similar in these groups of animals, as is the incorporation of (64)Cu into Cu-Zn superoxide dismutase both in cultured cerebellar neurons and in vivo. Our results differ from those of another set of published studies, and they require a re-evaluation of the role of PrP(C) in copper metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713045     DOI: 10.1074/jbc.275.11.7455

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.

Authors:  E Leclerc; D Peretz; H Ball; H Sakurai; G Legname; A Serban; S B Prusiner; D R Burton; R A Williamson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Location and properties of metal-binding sites on the human prion protein.

Authors:  G S Jackson; I Murray; L L Hosszu; N Gibbs; J P Waltho; A R Clarke; J Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Prion infection impairs the cellular response to oxidative stress.

Authors:  O Milhavet; H E McMahon; W Rachidi; N Nishida; S Katamine; A Mangé; M Arlotto; D Casanova; J Riondel; A Favier; S Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 4.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

Review 5.  Copper in microbial pathogenesis: meddling with the metal.

Authors:  Marie I Samanovic; Chen Ding; Dennis J Thiele; K Heran Darwin
Journal:  Cell Host Microbe       Date:  2012-02-16       Impact factor: 21.023

6.  Pseudoknots in prion protein mRNAs confirmed by comparative sequence analysis and pattern searching.

Authors:  I Barrette; G Poisson; P Gendron; F Major
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

7.  Recombinant prion protein does not possess SOD-1 activity.

Authors:  Samantha Jones; Mark Batchelor; Daljit Bhelt; Anthony R Clarke; John Collinge; Graham S Jackson
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

8.  A spectroscopic and voltammetric study of the pH-dependent Cu(II) coordination to the peptide GGGTH: relevance to the fifth Cu(II) site in the prion protein.

Authors:  Christelle Hureau; Laurent Charlet; Pierre Dorlet; Florence Gonnet; Lorenzo Spadini; Elodie Anxolabéhère-Mallart; Jean-Jacques Girerd
Journal:  J Biol Inorg Chem       Date:  2006-06-07       Impact factor: 3.358

Review 9.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

Review 10.  Copper and the prion protein: methods, structures, function, and disease.

Authors:  Glenn L Millhauser
Journal:  Annu Rev Phys Chem       Date:  2007       Impact factor: 12.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.